Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2014
04/08/2014US8691249 Peeling capsules
04/08/2014US8691246 Composition for forming a temporary intestinal occlusion in a mammal
04/08/2014US8691245 Composition for forming a temporary obstruction and method of forming the same
04/08/2014US8691203 Method comprising contacting tissue with a cross-linkable polyester prepolymer
04/08/2014US8690830 In-plane electromagnetic MEMS pump
04/08/2014CA2820479A1 Patch and method for producing the same
04/08/2014CA2748713C Composition including an active agent with low water solubility
04/08/2014CA2664548C Packaging for 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine-containing formulation
04/08/2014CA2655838C Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and method for its production
04/08/2014CA2653827C Novel blonanserin tape preparation
04/08/2014CA2644400C Fast wet-massing method for the preparation of calcium-containing compositions
04/08/2014CA2641575C Stabilization of solid thyroid drug formulations
04/08/2014CA2638914C Formulations for a tight junction effector
04/08/2014CA2629233C Cosmetic compositions with encapsulated pigments and a method for using
04/08/2014CA2629046C Abuse resistant transmucosal drug delivery device
04/08/2014CA2627223C Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate
04/08/2014CA2624568C Oligouronate treatment
04/08/2014CA2623848C Topical anesthetic for dental procedures
04/08/2014CA2615533C Oral, rapidly disintegrating film, which cannot be spat out, for a neuroleptic
04/08/2014CA2605773C Stable emulsion composition
04/08/2014CA2576556C Drug delivery device
04/08/2014CA2558219C Poorly water-soluble drug-containing solid formulation
04/08/2014CA2524773C Particulate coformulations of active substances with excipients
04/08/2014CA2456535C Personal care compositions with portable packs
04/05/2014CA2791427A1 Composition comprising streptococcus salivarius useful in the treatment of infections and/or inflammations of the upper respiratory tract
04/03/2014WO2014052971A1 Immunogenic compositions comprising nanoemulsions
04/03/2014WO2014052875A1 Stimulus-sensitive microparticles and methods of use
04/03/2014WO2014052837A1 Device and methods for sustained release of antipsychotic medications
04/03/2014WO2014052799A1 Tazobactam arginine antibiotic compositions
04/03/2014WO2014052678A1 Apixaban liquid formulations
04/03/2014WO2014052634A1 Lipid coated nanoparticles containing agents having low aqueous and lipid solubilities and methods thereof
04/03/2014WO2014052625A1 Insulin independence among patients with diabetes utilizing a ppi in combination with an immune tolerance agent
04/03/2014WO2014052566A1 Novel compounds that are erk inhibitors
04/03/2014WO2014052518A1 Biodegradable drug delivery systems for the sustained release of proteins
04/03/2014WO2014052453A1 Oral therapy of necrotizing enterocolitis
04/03/2014WO2014052311A1 Sonolysis with biodegradable nanoparticles
04/03/2014WO2014052264A1 Foaming skincare formulations
04/03/2014WO2014051835A1 Drug delivery device with multiple reservoirs
04/03/2014WO2014051834A1 Single channel, multiple drug delivery device
04/03/2014WO2014051532A1 Pharmaceutical tablet formulations comprising cefdinir
04/03/2014WO2014051443A1 Method for producing extended-release potassium citrate wax matrix tablet
04/03/2014WO2014051442A1 Veterinary pharmaceutical formulations and methods
04/03/2014WO2014051163A1 Pharmaceutical composition comprising rebamipide
04/03/2014WO2014051128A1 Transdermal patch
04/03/2014WO2014051025A1 Anagliptin-containing solid preparation
04/03/2014WO2014051024A1 Anagliptin-containing drug composition
04/03/2014WO2014051023A1 Anagliptin-containing preparation
04/03/2014WO2014050912A1 Liquid medicine having carbon dioxide dissolved therein, and therapeutic method using same
04/03/2014WO2014050910A1 Process for producing solid particles
04/03/2014WO2014050852A1 Ointment for mucosal application
04/03/2014WO2014050851A1 Oral liquid composition
04/03/2014WO2014050509A1 Liposome and liposome preparation
04/03/2014WO2014050301A1 Aqueous liquid medicine
04/03/2014WO2014050144A1 Dentinal tubule blocking agent
04/03/2014WO2014049606A2 Capsule for encapsulating a tablet
04/03/2014WO2014049548A1 Orodispersible films having quick dissolution times for therapeutic and food use
04/03/2014WO2014049300A1 Topical use of laropiprant for the treatment of rosacea
04/03/2014WO2014049298A1 Combination of laropiprant and ivermectin for the treatment of rosacea
04/03/2014WO2014049297A1 Combination of laropiprant and oxymetazoline for the treatment of rosacea
04/03/2014WO2014049296A1 Combination of laropiprant and metronidazole for the treatment of rosacea
04/03/2014WO2014049295A1 Combination of laropiprant and doxycycline for the treatment of rosacea
04/03/2014WO2014049140A1 Improvements in or relating to oromucosal apomorphine compositions
04/03/2014WO2014049112A1 Liquid concentrated vitamin e compositions
04/03/2014WO2014049073A1 Test for hemolytic potential of pharmaceutical products and formulations for risk minimization
04/03/2014WO2014048836A1 Stabilized aqueous compositions of neuromuscular blocking agents
04/03/2014WO2014048783A1 A storage-stable dust-free homogeneous particulate formulation comprising at least one water-soluble vitamin e-derivative and at least one hydrophilic polymer
04/03/2014WO2014048782A1 A storage-stable dust-free homogeneous particulate formulation comprising at least one water-soluble vitamin e-derivative and at least one hydrophilic polymer
04/03/2014WO2014048584A1 Composition containing lysine as a nutritional supplement or treatment in the case of herpes
04/03/2014WO2014048511A1 Metadoxine for use in the treatment of liver diseases, and metadoxine extended release formulations
04/03/2014WO2014048507A1 Process for preparing aqueous dispersions
04/03/2014WO2014048456A1 Device for electrochemically releasing a composition in a controlled manner
04/03/2014WO2014048380A1 Preparation method of agomelatine solid preparation
04/03/2014WO2014048106A1 Ant watered pill containing traditional chinese medicines and preparation method thereof
04/03/2014WO2014047731A1 Abuse deterrent pharmaceutical composition comprising konjac glucomannan
04/03/2014WO2014027981A3 Effervescent tablet formulations of dapoxetine and a pde5 inhibitor
04/03/2014WO2014023867A3 Liposomes administered indepently from the active agents
04/03/2014WO2014013090A3 Formulation comprising amorphous fingolimod
04/03/2014WO2013184037A3 Antibacterial pharmaceutical composition
04/03/2014WO2013180603A3 Method of production of biologically active complex-powder from the young shoots of sea buckthorn
04/03/2014WO2013092409A3 Active substance combinations of one or more aromatic alcohols and one or more physiologically acceptable hydroxamic acids, and cosmetic or dermatological preparations containing such active substance combinations
04/03/2014WO2012170047A3 Chewable supplement with live microorganisms
04/03/2014WO2012031046A3 Lipids suitable for liposomal delivery of protein-coding rna
04/03/2014WO2012009664A3 Bioadhesive compounds and methods of synthesis and use
04/03/2014US20140096284 Method for the delivery of molecules lyophilized onto microparticles to plant tissues
04/03/2014US20140094753 Infusion pump system, an infusion pump unit and an infusion pump
04/03/2014US20140094526 pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
04/03/2014US20140094510 Non-aqueous taxane nanodispersion formulations and methods of using the same
04/03/2014US20140094509 Non-aqueous taxane nanodispersion formulations and methods of using the same
04/03/2014US20140094481 Tamper resistant dosage forms
04/03/2014US20140094470 Combination treatment for dermatological conditions
04/03/2014US20140094469 Methods and compositions for safe and effective treatment of erythema
04/03/2014US20140094418 Palatable ductile chewable veterinary composition
04/03/2014US20140094399 Biodegradable poly(beta-amino esters) and uses thereof
04/03/2014US20140093594 Composition to Enhance the Bioavailability of Curcumin
04/03/2014US20140093582 Formulation for treatment of dry mouth and mouth sores
04/03/2014US20140093580 Silk-based drug delivery system
04/03/2014US20140093579 Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents
04/03/2014US20140093578 Novel clonidine formulation
04/03/2014US20140093577 Compositions and methods of making sustained release liquid formualtions
04/03/2014US20140093576 Pharmaceutical Dosage Form with Multiple Coatings for Reduced Impact of Coating Fractures
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 2991